Abstract
Phenylglyoxal (PGO), an arginine-modifying reagent, is an irreversible inhibitor of KAAT1-mediated leucine transport, expressed in Xenopus oocytes. The PGO effect was dose-dependent and 5 mm PGO determined a V(max) reduction to 24% of the control, consistent with the covalent binding to transporter arginine residues not located in the leucine binding site. The use of labelled [(14)C]PGO confirmed that the inhibitor binds KAAT1. The protein membrane domain contains seven arginine residues one of which, arginine 76, is conserved in the family of GABA transporters. Using site-directed mutagenesis we showed that only arginine 76 is crucial for KAAT1 activity and is involved in PGO binding.
MeSH terms
-
Amino Acid Transport Systems, Neutral*
-
Animals
-
Arginine / metabolism
-
Arginine / physiology*
-
Biological Transport / physiology*
-
Carrier Proteins / antagonists & inhibitors*
-
Carrier Proteins / genetics
-
Carrier Proteins / physiology
-
Electrophoresis, Polyacrylamide Gel
-
Gene Expression Regulation / physiology
-
Insect Proteins*
-
Kinetics
-
Lepidoptera / genetics
-
Lepidoptera / metabolism*
-
Leucine / metabolism
-
Membrane Glycoproteins / antagonists & inhibitors*
-
Membrane Glycoproteins / genetics
-
Membrane Glycoproteins / physiology
-
Mutagenesis, Site-Directed
-
Patch-Clamp Techniques
-
Phenylglyoxal / pharmacology*
-
Protein Structure, Secondary
-
Protein Structure, Tertiary
-
Xenopus laevis / genetics
-
Xenopus laevis / metabolism
Substances
-
Amino Acid Transport Systems, Neutral
-
Carrier Proteins
-
Insect Proteins
-
KAAT1 protein, insect
-
Membrane Glycoproteins
-
Arginine
-
Leucine
-
Phenylglyoxal